How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...
WPRI 1248m
CVS Health bulks its board up to 16 members, adds hedge fund CEO
The additions shouldn’t be surprising after Glenview acquired its stake and made public comments on the company, Leerink ...
bovnews1h
Why Did Wolfe Research Give Gilead Sciences, Inc. (GILD) Stock Outperform Rating?
On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...
bovnews2h
What’s Causing MannKind Corp (MNKD) Stock’s 48.15% Jump Over the Last Six Months?
On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...
CVS adds four new board members in deal with Glenview Capital
CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. The ...
Leerink Partnrs Has Negative Estimate for ARDT Q1 Earnings
Research analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of Ardent Health Partners in a ...
Leerink Partnrs Weighs in on Vincerx Pharma FY2024 Earnings
Equities researchers at Leerink Partnrs decreased their FY2024 earnings per share (EPS) estimates for Vincerx Pharma in a ...
Leerink Partners Sticks to Their Hold Rating for CureVac (CVAC)
Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...
Fintel on MSN4d
Leerink Partners Downgrades 908 Devices (MASS)
Fintel reports that on November 13, 2024, Leerink Partners downgraded their outlook for 908 Devices (NasdaqGM:MASS) from ...
Leerink Partners Keeps Their Hold Rating on Turnstone Biologics Corp. (TSBX)
In a report released yesterday, Daina Graybosch from Leerink Partners maintained a Hold rating on Turnstone Biologics Corp. (TSBX – ...
Fintel on MSN6d
Leerink Partners Upgrades Bristol-Myers Squibb (BMY)
Fintel reports that on November 12, 2024, Leerink Partners upgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from ...